🇺🇸 FDA
Patent

US 9877937

Compounds and methods for treating aberrant adrenocortical cell disorders

granted A61KA61K31/03A61K31/155

Quick answer

US patent 9877937 (Compounds and methods for treating aberrant adrenocortical cell disorders) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/03, A61K31/155, A61K31/17, A61K31/436